Related references
Note: Only part of the references are listed.State of the Art MR Imaging for Lung Cancer TNM Stage Evaluation
Yoshiharu Ohno et al.
CANCERS (2023)
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives
Alessandro Ottaiano et al.
CANCERS (2023)
Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials
Alessandro Ottaiano et al.
LANCET ONCOLOGY (2022)
Colorectal Cancer Preoperative Evaluation and Staging
Najjia N. Mahmoud
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2022)
Characterization of KRAS Mutational Regression in Oligometastatic Patients
Alessandro Ottaiano et al.
FRONTIERS IN IMMUNOLOGY (2022)
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review
Mariachiara Santorsola et al.
CANCERS (2022)
KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
Alessandro Ottaiano et al.
FRONTIERS IN ONCOLOGY (2021)
Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?
Alessandro Ottaiano et al.
TRANSLATIONAL ONCOLOGY (2021)
Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 Patients
Yuzuru Niibe et al.
ANTICANCER RESEARCH (2020)
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger et al.
LANCET ONCOLOGY (2020)
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer
Alessandro Ottaiano et al.
CELL DEATH & DISEASE (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Oligometastases: history and future vision of breast cancer
Yuzuru Niibe et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
Alessandro Ottaiano et al.
CANCERS (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios
Nicola Normanno et al.
CANCER TREATMENT REVIEWS (2018)
Oligo-recurrence and Sync-oligometastases In Response
Yuzuru Niibe et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial
N. Normanno et al.
ANNALS OF ONCOLOGY (2015)
Next-generation sequencing in the clinic: Promises and challenges
Jiekun Xuan et al.
CANCER LETTERS (2013)
Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature
Yuzuru Niibe et al.
PULMONARY MEDICINE (2012)
Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy
Yuzuru Niibe et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)